Croda International Plc (LON:CRDA – Get Free Report) insider Steve Foots bought 3,815 shares of the stock in a transaction on Monday, August 4th. The stock was purchased at an average price of GBX 2,617 ($35.19) per share, with a total value of £99,838.55 ($134,263.78).
Steve Foots also recently made the following trade(s):
- On Tuesday, July 15th, Steve Foots acquired 5 shares of Croda International stock. The stock was acquired at an average cost of GBX 2,987 ($40.17) per share, with a total value of £149.35 ($200.85).
- On Monday, May 12th, Steve Foots purchased 5 shares of Croda International stock. The shares were acquired at an average price of GBX 3,196 ($42.98) per share, for a total transaction of £159.80 ($214.90).
Croda International Stock Performance
Shares of LON CRDA opened at GBX 2,594 ($34.88) on Friday. The company has a debt-to-equity ratio of 30.90, a quick ratio of 2.25 and a current ratio of 2.72. The company has a market capitalization of £3.63 billion, a PE ratio of 22.29, a price-to-earnings-growth ratio of 1.40 and a beta of 0.74. Croda International Plc has a 1 year low of GBX 2,527 ($33.98) and a 1 year high of GBX 4,335 ($58.30). The company’s fifty day moving average price is GBX 2,930.41 and its 200 day moving average price is GBX 3,007.94.
Analysts Set New Price Targets
A number of equities analysts recently issued reports on CRDA shares. Berenberg Bank reduced their target price on Croda International from GBX 3,800 ($51.10) to GBX 3,100 ($41.69) and set a “buy” rating for the company in a research note on Tuesday, July 29th. JPMorgan Chase & Co. raised Croda International to an “overweight” rating in a report on Wednesday, July 30th. Deutsche Bank Aktiengesellschaft decreased their target price on Croda International from GBX 3,400 ($45.72) to GBX 3,000 ($40.34) and set a “hold” rating for the company in a report on Tuesday, July 29th. Finally, Citigroup decreased their target price on Croda International from GBX 3,550 ($47.74) to GBX 3,300 ($44.38) and set a “neutral” rating for the company in a report on Tuesday, April 29th.
Read Our Latest Stock Analysis on Croda International
About Croda International
Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world.
Read More
- Five stocks we like better than Croda International
- What is the Euro STOXX 50 Index?
- Why Monolithic Power’s Earnings and Guidance Ignited a Rally
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- AppLovin’s Q2 Miss Spooks Market, But Wall Street Doubles Down
- What Makes a Stock a Good Dividend Stock?
- Microsoft Stock Gains as Analysts Boost Price Targets
Receive News & Ratings for Croda International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Croda International and related companies with MarketBeat.com's FREE daily email newsletter.